Management of thymic epithelial tumors (TETs) at the National Cancer Institute (NCI)

被引：0
|
作者：
Rajan, A. [1 ]
Kelly, R. J. [1 ]
Lopez-Chavez, A. [1 ]
Carter, C. A. [1 ]
Szabo, E. [1 ]
Scepura, B. [1 ]
Manu, M. J. [1 ]
Berman, A. W. [1 ]
Giaccone, G. [1 ]
机构：
[1] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e17511
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17511
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mesothelin expression in thymic epithelial tumors (TETs)
    Chen, Yuanbin
    Thomas, Anish
    Berman, Arlene W.
    Miettinen, Markku
    Hassan, Raffit
    Rajan, Arun
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Thymic epithelial tumors (TETs) and additional tumors: a single Centre experience
    Paolucci, V.
    Marcantognini, G.
    Maccaroni, E.
    Mazzanti, P.
    Goteri, G.
    Sabbatini, A.
    Berardi, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] Clinical and histologic correlation of thymic epithelial tumors (TETs) in Korea
    Kim, S
    Lee, J
    Park, J
    Kang, J
    Han, J
    Shim, Y
    Kim, J
    Kwon, O
    Kim, H
    Park, K
    LUNG CANCER, 2005, 49 : S292 - S292
  • [4] INTERROGATION OF IMMUNE TOXICITY IN PATIENTS WITH THYMIC EPITHELIAL TUMORS (TETS)
    McAdams, Meredith
    Swift, Shannon
    Ballman, Madison
    Wong-Rolle, Abigail
    Donahue, Renee
    Palena, Claudia
    Schlom, Jeffrey
    Gulley, James
    Rajan, Arun
    Zhao, Chen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A459 - A459
  • [5] Thymic tumors: Experience of the National Cancer Institute of Colombia
    Ricardo Buitrago-Ramirez, Miguel
    Jussef Mantilla-Gaviria, Habib
    Carreno Duenas, Jose Alexander
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2019, 23 (03): : 92 - 98
  • [6] Cancer activation pathways of thymic epithelial tumors (TETs) by targeted gene expression analysis.
    Benitez, Jose Carlos
    Job, Bastien
    de Montpreville, Vincent Thomas
    Lacroix, Ludovic
    Saulnier, Patrick
    Arana, Riad
    Lambotte, Olivier
    Mussot, Sacha
    Mercier, Olaf
    Fadel, Elie
    Scoazec, Jean-Yves
    Besse, Benjamin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Clinical and histologic correlation of thymic epithelial tumors (TETs) in Korea.
    Kim, ST
    Park, JO
    Park, J
    Han, JH
    Kim, JG
    Shim, YM
    Park, YS
    Im, YH
    Kang, WK
    Park, K
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 689S - 689S
  • [8] Effect of treatment on the regression and growth rates of thymic epithelial tumors (TETs).
    Pichun, Mauricio Emmanuel Burotto
    Thomas, Anish
    Wilkerson, Julia
    Hassan, Raffit
    Fojo, Antonio Tito
    Giaccone, Giuseppe
    Rajan, Arun
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Tyrosine Kinase Inhibitors (Alone or in Combination) for the Management of Advanced Thymic Epithelial Tumors (TETs) Among Hispanics
    de Lima, V. C. C.
    Freitas, H.
    Florez, J. D.
    Ruiz-Patino, A.
    Cardona, A. F.
    Mejia, S.
    Rojas, L.
    Zuluaga, J.
    Corrales, L.
    Martin, C.
    Mas, L.
    Motta, R.
    Viola, L.
    Martinez, S.
    Carvajal, C.
    Wagner-Gutierrez, N.
    Sanchez, N.
    Pino, L. E.
    Raez, L.
    Rolfo, C.
    Arrieta, O.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S275 - S276
  • [10] Circulating T-cell immunosenescence in patients with thymic epithelial tumors (TETs)
    Benitez, J. C.
    Naigeon, M.
    Lambotte, O.
    De Montpreville, V. T.
    Mussot, S.
    Mercier, O.
    Fadel, E.
    Scoazec, J-Y.
    Planchard, D.
    Lavaud, P.
    Abdayem, P.
    Naltet, C.
    Barlesi, F.
    Soria, J-C.
    Saada, V.
    Chaput, N.
    Besse, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S1200 - S1201
12345